| SONVY Stock | | | USD 66.20 1.27 1.96% |
COO
Mr. Arnd Kaldowski was Chairman of the Management Board, Chief Executive Officer at Sonova Holding Ltd. since April 1, 2018. He was Chief Operating Officer, Member of the Management Board of the Company from October 1, 2017. He joined Sonova from Danaher Corporationrationration, where he served in various leadership capacities since 2008, most recently as Group Executive of the Diagnostics Platform and President Beckman Coulter Diagnostics. He served as Senior Vice President PointofCare Solutions at Siemens Medical, following his previous assignments as Investment Director of Atila Ventures and as a Manager with the Boston Consulting Group since 2018.
| Age | 56 |
| Tenure | 6 years |
| Professional Marks | MBA |
| Phone | 41 58 928 33 33 |
| Web | https://www.sonova.com |
Kaldowski holds a MS in Physics from the Technical University Darmstadt, Germany, and an MBA from INSEAD in Fontainebleau, France.
Sonova Holding Management Efficiency
The company has return on total asset
(ROA) of
0.0879 % which means that it generated a profit of $0.0879 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
0.2878 %, meaning that it generated $0.2878 on every $100 dollars invested by stockholders. Sonova Holding's management efficiency ratios could be used to measure how well Sonova Holding manages its routine affairs as well as how well it operates its assets and liabilities.
Sonova Holding AG has accumulated 864.9
M in total debt with debt to equity ratio
(D/E) of 0.61, which is about average as compared to similar companies. Sonova Holding AG has a current ratio of 1.08, suggesting that it
may have difficulties to pay its financial obligations in time and when they become due. Debt can assist Sonova Holding until it has trouble settling it off, either with new capital or with free cash flow. So, Sonova Holding's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Sonova Holding AG sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Sonova to invest in growth at high rates of return. When we think about Sonova Holding's use of debt, we should always consider it together with cash and equity.
Sonova Holding AG designs, develops, manufactures, and distributes hearing care solutions for adults and children. Sonova Holding AG was founded in 1947 and is headquartered in Stfa, Switzerland. SONOVA HOLDING operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 16733 people. Sonova Holding AG [SONVY] is a
Pink Sheet which is traded between brokers as part of OTC trading.
Management Performance
Sonova Holding AG Leadership Team
Elected by the shareholders, the Sonova Holding's board of directors comprises two types of representatives: Sonova Holding inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sonova. The board's role is to monitor Sonova Holding's management team and ensure that shareholders' interests are well served. Sonova Holding's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sonova Holding's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Christophe Fond, Group Vice President Retail | |
| Robert Woolley, Group Board | |
| Jan Metzdorff, Member of the Management Board | |
| Ludger Althoff, Vice President - Operations | |
| Arnd Kaldowski, COO, Member of the Management Board | |
| Claudio Bartesaghi, Member of the Management Board, Group Vice President Corporate Human Resources, Corporate Communications | |
| Thomas Bernhardsgrutter, Director Relations | |
| Martin Grieder, Vice President Phonak, Member of the Management Board | |
| Birgit Conix, CFO Board | |
| Victoria CarrBrendel, Group Vice President Cochlear Implants and Presidentident of Advanced Bionics and Member of the Management Board | |
Sonova Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Sonova Holding a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Sonova Pink Sheet Analysis
When running Sonova Holding's price analysis, check to
measure Sonova Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sonova Holding is operating at the current time. Most of Sonova Holding's value examination focuses on studying past and present price action to
predict the probability of Sonova Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sonova Holding's price. Additionally, you may evaluate how the addition of Sonova Holding to your portfolios can decrease your overall portfolio volatility.